- Title Pages
- Title Pages
- Acknowledgments
- Introduction
- Harnessing Stem Cells for Regenerative Medicine
-
Dialogue 1 Hope -
Dialogue 2 Why is this Cell Different from Other Cells? -
Dialogue 3 The President’s Stem Cells -
Dialogue 4 The Dickey-Wicker Enigma -
Dialogue 5 The Moral Status of Embryos -
Dialogue 6 Creating Good from Immoral Acts -
Dialogue 7 Circumventing Embryocide -
Dialogue 8 My Personalized Beta Cells for Diabetes -
Dialogue 9 Repairing Brain Cells in Stroke Victims -
Dialogue 10 Reversing Macular Degeneration -
Dialogue 11 My Stem Cells, My Cancer -
Dialogue 12 Reprogramming Cells -
Dialogue 13 My Personalized Disease Cells -
Dialogue 14 To Clone or not to Clone -
Dialogue 15 Patenting Human Embryonic Stem Cells is Immoral and Illegal (In Europe) -
Dialogue 16 My Embryo is Auctioned on the Internet -
Dialogue 17 Here Comes the Egg Man -
Dialogue 18 Human-Animal Chimeras and Hybrids -
Dialogue 19 Stem Cell Tourism -
Dialogue 20 Social Media Meet Science Hype -
Dialogue 21 Feminism and the Commercialization of Human Eggs/Embryos -
Dialogue 22 Was My Birth Embryo Me? -
Dialogue 23 Embryos without Ovaries -
Dialogue 24 How My Cells Became Drugs -
Dialogue 25 A Clinical Trial for Paralysis Treatment - Epilogue
- Glossary
- Index
A Clinical Trial for Paralysis Treatment
A Clinical Trial for Paralysis Treatment
- Chapter:
- (p.181) Dialogue 25 A Clinical Trial for Paralysis Treatment
- Source:
- Stem Cell Dialogues
- Author(s):
Sheldon Krimsky
- Publisher:
- Columbia University Press
This dialogue is a fictional account of science reporter Valerie Legere's interview with Dr. Fred Lincoln, a medical doctor working for Geron Corporation of Menlo Park, California. Geron was the first company in the United States to have an investigative new drug (IND) involving stem cells approved for a clinical trial on patients with acute spinal cord injury. Lincoln is overseeing the trial. Dr. Rebecca Franklin has been a short-term consultant to Geron on the ethics and science of the clinical trials because of her work on stem cells for repairing her father's spinal cord injury. Here Lincoln talks to Legere about the risks and benefits of the trial, how the trial works, the form of stem cell therapy that trial participants will receive, positive and negative outcomes expected from the trial and the precautions that Geron has been taking to prevent negative outcomes, and why the Food and Drug Administration stopped Geron's first trial in 2009.
Keywords: investigative new drug, stem cells, spinal cord injury, ethics, clinical trials, stem cell therapy, Food and Drug Administration
Columbia Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.
Please, subscribe or login to access full text content.
If you think you should have access to this title, please contact your librarian.
To troubleshoot, please check our FAQs, and if you can't find the answer there, please contact us .
- Title Pages
- Title Pages
- Acknowledgments
- Introduction
- Harnessing Stem Cells for Regenerative Medicine
-
Dialogue 1 Hope -
Dialogue 2 Why is this Cell Different from Other Cells? -
Dialogue 3 The President’s Stem Cells -
Dialogue 4 The Dickey-Wicker Enigma -
Dialogue 5 The Moral Status of Embryos -
Dialogue 6 Creating Good from Immoral Acts -
Dialogue 7 Circumventing Embryocide -
Dialogue 8 My Personalized Beta Cells for Diabetes -
Dialogue 9 Repairing Brain Cells in Stroke Victims -
Dialogue 10 Reversing Macular Degeneration -
Dialogue 11 My Stem Cells, My Cancer -
Dialogue 12 Reprogramming Cells -
Dialogue 13 My Personalized Disease Cells -
Dialogue 14 To Clone or not to Clone -
Dialogue 15 Patenting Human Embryonic Stem Cells is Immoral and Illegal (In Europe) -
Dialogue 16 My Embryo is Auctioned on the Internet -
Dialogue 17 Here Comes the Egg Man -
Dialogue 18 Human-Animal Chimeras and Hybrids -
Dialogue 19 Stem Cell Tourism -
Dialogue 20 Social Media Meet Science Hype -
Dialogue 21 Feminism and the Commercialization of Human Eggs/Embryos -
Dialogue 22 Was My Birth Embryo Me? -
Dialogue 23 Embryos without Ovaries -
Dialogue 24 How My Cells Became Drugs -
Dialogue 25 A Clinical Trial for Paralysis Treatment - Epilogue
- Glossary
- Index